VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BROBrown & Brown, Inc.
$64.22$21.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksBROFinancials

Brown & Brown, Inc. (BRO) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 37.3% in 2026Q1, though earnings remain sensitive to acquisition-related accounting as evidenced by the 19.2% EPS decline observed in 2025Q4.

BRO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue6.42B5.96B4.71B4.2B3.56B3.05B2.61B2.38B2.01B1.86B1.76B1.66B1.57B1.36B1.19B1.01B966.92M967.88M977.55M959.67M878M785.81M646.93M546.72M455.74M365.03M265.4M188.39M171.49M143.5M128.16M
Revenue Growth %33.46%26.59%12.05%17.85%16.92%16.94%9.28%18.65%8.22%5.36%6.39%5.71%15.64%14%18.2%4.04%-0.1%-0.99%1.86%9.3%11.73%21.47%18.33%19.96%24.85%37.54%40.88%9.86%19.5%11.97%20.49%
Medical Costs & Claims2.61B734M2.41B2.19B1.82B1.64B1.44B1.31B1.07B994.65M925.22M856.95M811.11M683M608.51M508.68M487.82M0000374.94M0268.37M00000028.08M
Medical Cost Ratio %40.62%12.32%51.14%52.08%51%53.71%55.12%54.86%53.18%53.55%52.49%51.72%51.75%50.39%51.17%50.57%50.45%0%0%0%0%47.71%0%49.09%0%0%0%0%0%0%21.91%
Gross Profit3.81B5.22B2.3B2.01B1.75B1.41B1.17B1.08B940.94M862.62M837.57M800M756.35M672.5M580.58M497.29M479.1M967.88M977.55M959.67M878M407.18M646.93M278.34M455.74M365.03M265.4M188.39M171.49M143.5M100.08M
Gross Margin %59.38%87.68%48.86%47.92%49%46.29%44.88%45.14%46.82%46.45%47.51%48.28%48.25%49.61%48.83%49.43%49.55%100%100%100%100%51.82%100%50.91%100%100%100%100%100%100%78.09%
Gross Profit Growth %-127.14%14.26%15.23%23.78%20.59%8.65%14.41%9.08%2.99%4.7%5.77%12.47%15.83%16.75%3.8%-50.5%-0.99%1.86%9.3%115.63%-37.06%132.42%-38.93%24.85%37.54%40.88%9.86%19.5%43.38%19.98%
Operating Expenses2.09B3.53B932M856M783M555.9M500.8M505.8M441.5M391.61M370.54M359.37M339.16M303.7M269.2M222.42M206.78M698.52M690.37M634.34M584.61M152.26M432.83M102.56M316.42M268.85M210.07M143.55M-42.1M-36.61M71.75M
OpEx / Revenue %32.59%59.22%19.81%20.39%21.98%18.24%19.22%21.21%21.97%21.09%21.02%21.69%21.64%22.4%22.64%22.11%21.39%72.17%70.62%66.1%66.58%19.38%66.9%18.76%69.43%73.65%79.15%76.2%-24.55%-25.51%55.98%
Depreciation & Amortization427M367M222M206M186M152.9M134.8M128.72M109.38M108.14M107.67M108.31M103.84M85.42M78.95M67.15M64.08M63.1M59.92M53.2M47.81M43.31M31.06M25.67M21.29M22.4M15.38M12.24M9.82M8.83M5.21M
Combined Ratio %73.21%71.54%70.95%72.47%72.97%71.95%74.33%76.07%75.15%74.64%73.51%73.41%73.38%72.79%73.81%72.68%71.84%72.17%70.62%66.1%66.58%67.09%66.9%67.85%69.43%73.65%79.15%76.2%-24.55%-25.51%77.89%
Operating Income1.72B1.7B1.37B1.16B963M854.7M668.9M570.77M499.45M471M467.03M440.63M417.18M368.81M311.38M274.87M272.32M269.35M287.19M325.33M293.4M258.6M214.1M175.78M139.32M96.18M55.33M44.84M213.59M180.11M28.33M
Operating Margin %26.79%28.46%29.05%27.53%27.03%28.05%25.67%23.93%24.85%25.36%26.49%26.59%26.62%27.21%26.19%27.32%28.16%27.83%29.38%33.9%33.42%32.91%33.1%32.15%30.57%26.35%20.85%23.8%124.55%125.51%22.11%
Operating Income Growth %-23.99%18.25%20.04%12.67%27.78%17.19%14.28%6.04%0.85%5.99%5.62%13.12%18.44%13.28%0.94%1.1%-6.21%-11.72%10.88%13.46%20.78%21.8%26.17%44.86%73.83%23.4%-79.01%18.58%535.68%7395.77%
EBITDA2.15B2.06B1.59B1.36B1.15B1.01B803.7M699.48M608.83M579.15M574.7M548.94M521.02M454.22M390.32M342.01M336.4M332.45M347.11M378.53M341.2M301.9M245.16M201.45M160.61M118.58M70.71M57.07M223.4M188.94M33.54M
EBITDA Margin %33.43%34.62%33.77%32.44%32.25%33.06%30.84%29.33%30.29%31.18%32.6%33.13%33.24%33.51%32.83%34%34.79%34.35%35.51%39.44%38.86%38.42%37.9%36.85%35.24%32.48%26.64%30.29%130.28%131.67%26.17%
Interest Expense253M297M201M197M148M65M59M63.66M40.58M38.32M39.48M39.25M28.41M16.44M16.1M14.13M14.47M14.6M14.69M13.8M13.36M14.47M7.16M3.62M0000000
Non-Operating Income-19M27M-137M-187M-61M26.9M-14.2M-18.82M-3.6M-17.03M4.05M-1.17M49.03M-5.24M-9.53M-9.79M-8.25M000000-4.33M0000000
Pretax Income1.48B1.37B1.3B1.15B876M762.8M624.1M525.93M462.46M449.72M423.5M402.56M339.75M357.61M304.81M270.52M266.1M254.75M272.5M311.53M280.04M244.13M206.95M176.48M134.66M90.48M54.06M44.01M38.6M30.98M27.36M
Pretax Margin %22.97%23.02%27.69%27.29%24.59%25.03%23.95%22.05%23.01%24.21%24.02%24.3%21.68%26.38%25.63%26.89%27.52%26.32%27.88%32.46%31.9%31.07%31.99%32.28%29.55%24.79%20.37%23.36%22.51%21.59%21.35%
Income Tax319M304M301M275.6M204.3M175.7M143.6M127.42M118.21M50.09M166.01M159.24M132.85M140.5M120.77M106.53M104.35M101.46M106.37M120.57M107.69M93.58M78.11M66.16M49.27M34.83M20.15M17.04M15.04M12M10.6M
Effective Tax Rate %21.61%22.17%23.1%24.05%23.32%23.03%23.01%24.23%25.56%11.14%39.2%39.56%39.1%39.29%39.62%39.38%39.21%39.83%39.04%38.7%38.46%38.33%37.74%37.49%36.59%38.5%37.26%38.71%38.96%38.72%38.72%
Net Income1.15B1.05B993M870.5M671.8M587.1M480.5M398.51M344.25M399.63M257.49M243.32M206.9M217.11M184.04M164M161.75M153.29M166.12M190.96M172.35M150.55M128.84M110.32M83.12M53.91M32.79M26.79M23.56M18.99M16.77M
Net Margin %17.87%17.7%21.11%20.73%18.85%19.26%18.44%16.71%17.13%21.52%14.61%14.68%13.2%16.02%15.48%16.3%16.73%15.84%16.99%19.9%19.63%19.16%19.92%20.18%18.24%14.77%12.36%14.22%13.74%13.23%13.08%
Net Income Growth %11.24%6.14%14.07%29.58%14.43%22.19%20.57%15.76%-13.86%55.2%5.82%17.6%-4.71%17.97%12.23%1.39%5.52%-7.72%-13.01%10.8%14.48%16.85%16.79%32.72%54.18%64.4%22.41%13.7%24.09%13.25%13.3%
EPS (Diluted)3.393.163.463.052.372.071.691.401.221.410.910.850.710.740.630.560.560.540.590.680.610.540.470.400.310.210.070.120.050.060.01
EPS Growth %-8.06%-8.67%13.44%28.69%14.49%22.49%20.71%14.75%-13.48%54.95%7.06%19.72%-4.05%17.46%12.5%0%3.7%-8.47%-13.24%11.48%12.96%14.89%17.5%29.03%47.62%216.74%-44.75%131.21%-10.36%366.94%13.76%
EPS (Basic)-3.403.483.072.382.081.701.421.241.430.920.860.720.750.640.570.570.540.590.680.620.550.470.410.310.220.070.080.050.060.01
Diluted Shares Outstanding339M313M284M280.8M278.6M277.41M275.87M274.62M282.21M277.59M275.61M280.22M285.78M285.25M284.02M280.53M278.64M275.01M283.12M272.71M282.04M279.55M277.78M275.59M272.17M252.89M494.61M338.97M454.08M327.34M135.51M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Integration and Talent Costs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Aggressive Revenue Expansion Through Acquisitions

As reported in recent financial filings, Brown & Brown achieved a significant 37.3% year-over-year revenue growth in 2026Q1, signaling that the company's aggressive tuck-in acquisition strategy and exposure to hard market pricing conditions are successfully driving top-line expansion beyond historical organic growth norms for the brokerage sector.

The acceleration in revenue growth suggests that the integration of recent large-scale acquisitions, such as Global Risk Partners, is contributing meaningfully to the consolidated top line. Investors should monitor whether this growth trajectory remains sustainable as the company faces potential headwinds from a moderating insurance pricing cycle.

Underwriting Efficiency Amidst Scale Expansion

Based on the provided income statement data, the company maintained a combined ratio of 72.0% in 2026Q1, which indicates that Brown & Brown continues to operate with high underwriting efficiency despite the complexities introduced by its rapid international expansion and ongoing integration of new business units.

The consistent ability to keep the combined ratio well below the 100% threshold suggests that the firm's decentralized operating model effectively manages costs even as the organization scales. This margin profile appears to be a key differentiator, potentially insulating the firm from the competitive pressures that typically compress brokerage margins.

Operational Leverage and Talent Sensitivity

According to the latest quarterly results, the company's operating income reached $533.0 million in 2026Q1, reflecting a strong ability to convert premium growth into bottom-line earnings while managing the high variable compensation costs inherent in the talent-dependent insurance brokerage and MGA business model.

The firm's reliance on specialized talent suggests that operating margins may remain sensitive to wage inflation and the competitive market for experienced producers. Analysts should investigate whether the current level of operating leverage can be maintained if the company continues to pursue larger, more complex international deals.

Earnings Volatility from Acquisition Accounting

As indicated by the historical quarterly data, EPS growth has shown significant volatility, including a 19.2% decline in 2025Q4, which warrants further investigation into the impact of contingent consideration adjustments and the amortization of intangible assets on the company's reported GAAP net income figures.

The fluctuation in quarterly earnings suggests that headline GAAP figures may not fully capture the underlying cash-generating power of the business. Investors should be cautious of relying solely on net income, as earn-out adjustments related to the firm's frequent M&A activity can create artificial noise in the income statement.

BRO — Frequently Asked Questions

Quick answers to the most common questions about buying BRO stock.

What was Brown & Brown, Inc.'s (BRO) revenue in 2025?

For fiscal year 2025, Brown & Brown, Inc. (BRO) reported total revenue of $5.96B. This represents a 4547.3% increase compared to $128.2M in 1996.

Is Brown & Brown, Inc. (BRO) profitable?

Brown & Brown, Inc. (BRO) is profitable, generating $1.05B in net income for the fiscal year ending 2025 with a net profit margin of 17.7%.

What is Brown & Brown, Inc.'s operating profit margin?

Brown & Brown, Inc. (BRO) reported an operating income of $1.70B, resulting in an operating profit margin of 28.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Brown & Brown, Inc.'s gross profit and gross margin?

Brown & Brown, Inc. (BRO) generated $5.22B in gross profit for the year, representing a gross profit margin of 87.7%. This demonstrates the company's core pricing power and production efficiency.